Comment on: Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease

Mitsuhiro Akiyama; Yuko Kaneko

doi:10.1093/rheumatology/keab687

Comment on: Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease

Mitsuhiro Akiyama, Yuko Kaneko

内科学(リウマチ・膠原病)

研究成果: Letter › 査読

1 被引用数 (Scopus)

本文言語	English
ページ（範囲）	E412-E413
ジャーナル	Revmatologiia (Bulgaria)
巻	60
号	11
DOI	https://doi.org/10.1093/rheumatology/keab687
出版ステータス	Published - 2021 11月 1

ASJC Scopus subject areas

リウマチ学

文献へのアクセス

10.1093/rheumatology/keab687

他のファイルとリンク

引用スタイル

@article{3921b9d7ae954f0a9fb5d2c725898dc5,

title = "Comment on: Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease",

author = "Mitsuhiro Akiyama and Yuko Kaneko",

note = "Funding Information: This work was supported by a Japan Society for the Promotion of Science KAKENHI grant (21K16292) to M.A. ",

year = "2021",

month = nov,

day = "1",

doi = "10.1093/rheumatology/keab687",

language = "English",

volume = "60",

pages = "E412--E413",

journal = "Revmatologiia (Bulgaria)",

issn = "1310-0505",

publisher = "Meditsiinski Unversitet-Sofia",

number = "11",

}

TY - JOUR

T1 - Comment on

T2 - Persistence of circulating T-follicular helper cells after rituximab is associated with relapse of IgG4-related disease

AU - Akiyama, Mitsuhiro

AU - Kaneko, Yuko

N1 - Funding Information: This work was supported by a Japan Society for the Promotion of Science KAKENHI grant (21K16292) to M.A.

PY - 2021/11/1

Y1 - 2021/11/1

UR - http://www.scopus.com/inward/record.url?scp=85121940789&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121940789&partnerID=8YFLogxK

U2 - 10.1093/rheumatology/keab687

DO - 10.1093/rheumatology/keab687

M3 - Letter

C2 - 34505901

AN - SCOPUS:85121940789

SN - 1310-0505

VL - 60

SP - E412-E413

JO - Revmatologiia (Bulgaria)

JF - Revmatologiia (Bulgaria)

IS - 11

ER -